Samjin Pharmaceuticals Market Cap

Samjin Pharmaceuticals has a market cap or net worth of 217.07 billion as of February 21, 2025. Its market cap has decreased by -16.91% in one year.

Market Cap

217.07B

Enterprise Value

n/a

Revenue

274.03B

Ranking

n/a

PE Ratio

10.24

Stock Price

17,700.00

Market Cap Chart

Since August 30, 1995, Samjin Pharmaceuticals's market cap has increased from 29.12B to 217.07B, an increase of 645.45%. That is a compound annual growth rate of 7.05%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	217.07B	-2.05%
Dec 30, 2024	221.61B	-19.69%
Dec 28, 2023	275.94B	-19.80%
Dec 29, 2022	344.07B	5.06%
Dec 30, 2021	327.51B	-3.49%
Dec 30, 2020	339.34B	9.22%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	81.78T
Celltrion	38.27T
Yuhan	9,148.44B
SK Biopharmaceuticals	9,053.01B
SK bioscience	3,756.75B
Hanmi Pharm.	3,417.32B
Hanmi Science	1,963.70B
Hanall Biopharma	1,934.60B

Market Cap Rankings